39786-34-0

Basic information

• Product Name: Ethyl 2-(2-cyanophenoxy)acetate ,96%
• Synonyms: Ethyl 2-(2-cyanophenoxy)acetate ,96%;2-(2-cyanophenoxy)Acetic acid ethyl ester
• CAS NO: 39786-34-0
• Molecular Formula: C₁₁H₁₁NO₃
• Molecular Weight: 205
• Mol File: 39786-34-0.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: Ethyl 2-(2-cyanophenoxy)acetate ,96%(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl 2-(2-cyanophenoxy)acetate ,96%(39786-34-0)
• EPA Substance Registry System: Ethyl 2-(2-cyanophenoxy)acetate ,96%(39786-34-0)

Safety Data

• Statements: 36/37/38
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 39786-34-0(Hazardous Substances Data)

Usage

Chemical Properties

White needlepoint crystal

Upstream product

• 611-20-1 salicylonitrile 
• 105-36-2 ethyl bromoacetate 

Downstream Products

• 328009-03-6 (4-bromo-2-cyanophenoxy)acetic acid ethyl ester 
• 688757-29-1 Ethyl (E)-3-(3-phenylacryloylamino)benzofurane-2-carboxylate 
• 636992-58-0 (E)-[2-cyano-4-(2-diethylcarbamoyl-1-methylvinyl)phenoxy]acetic acid ethyl ester 
• 330555-71-0 ethyl 3-amino-5-bromo-1-benzofuran-2-carboxylate 

Relevant articles and documents

COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CFTR

The present disclosure is directed to disclosed compounds that modulate, e.g., address underlying defects in cellular processing of CFTR activity.

SUBSTITUTED TRICYCLIC PYRIDINE OR PYRIMIDINE VANILLOID RECEPTOR LIGANDS

The present invention relates to substituted tricyclic compounds, which can be used as vanilloid receptor ligands. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by vanilloid receptor-1 (VRl). Also provided herein are pharmaceutical compositions and methods for treating or preventing diseases, conditions and/or disorders modulated by VRl.

Degradation-promoters of cellular inhibitor of apoptosis protein 1 based on bestatin and actinonin

A series of hybrid compounds of bestatin (1) and actinonin (3), which promote degradation of cellular inhibitor of apoptosis protein 1 (cIAP1), were designed and synthesized. Structure-activity relationship studies indicated that absolute configuration, hydrophobicity at the α-position of the internal amide carbonyl group, and the presence of a small substituent at the α-position of the ester group are important factors for the expression of potent cIAP1 degradation-promoting activity. HAB-5A (30b) showed the most potent activity (IC50 = 0.53 μM) among the compounds prepared.